Skip to main content
Data in Brief logoLink to Data in Brief
. 2016 Apr 7;7:1288–1295. doi: 10.1016/j.dib.2016.03.106

Data in support of transcriptional regulation and function of Fas-antisense long noncoding RNA during human erythropoiesis

Olga Villamizar a,1,2, Christopher B Chambers a,1, Yin-Yuan Mo a,c, Donald S Torry a,b, Reese Hofstrand a, Janice M Riberdy d, Derek A Persons d, Andrew Wilber a,b,
PMCID: PMC4838931  PMID: 27141526

Abstract

This paper describes data related to a research article titled, “Fas-antisense long noncoding RNA is differentially expressed during maturation of human erythrocytes and confers resistance to Fas-mediated cell death” [1]. Long noncoding RNAs (lncRNAs) are increasingly appreciated for their capacity to regulate many steps of gene expression. While recent studies suggest that many lncRNAs are functional, the scope of their actions throughout human biology is largely undefined including human red blood cell development (erythropoiesis). Here we include expression data for 82 lncRNAs during early, intermediate and late stages of human erythropoiesis using a commercial qPCR Array. From these data, we identified lncRNA Fas-antisense 1 (Fas-AS1 or Saf) described in the research article. Also included are 5′ untranslated sequences (UTR) for lncRNA Saf with transcription factor target sequences identified. Quantitative RT-PCR data demonstrate relative levels of critical erythroid transcription factors, GATA-1 and KLF1, in K562 human erythroleukemia cells and maturing erythroblasts derived from human CD34+ cells. End point and quantitative RT-PCR data for cDNA prepared using random hexamers versus oligo(dT)18 revealed that lncRNA Saf is not effectively polyadenylated. Finally, we include flow cytometry histograms demonstrating Fas levels on maturing erythroblasts derived from human CD34+ cells transduced using mock conditions or with lentivirus particles encoding for Saf.

Keywords: Erythropoiesis, Long noncoding RNA, Saf, Apoptosis, Fas

Specifications table

Subject area Cell Biology, Biochemistry
More specific subject area Erythropoiesis, transcription, apoptosis
Type of data Table and Figures
How data was acquired Quantitative RT-PCR (StepOnePlus Thermocycler, Applied Biosystems)
Flow cytometry (FACSAriaII, BD Biosciences) using FlowJo v10.0 analysis software.
Data format Processed/Analyzed data
Experimental factors Isolation of total cellular RNA, cDNA amplification, PCR analysis, antibody staining of cells
Experimental features Analysis of gene expression by quantitative RT-PCR and flow cytometry
Data source location Springfield, IL, United States
Data accessibility Data is with this article.

Value of the data

  • Expression data for 82 long noncoding RNAs at early and late stages of human erythroid maturation are provided.

  • Methods to determine poly-adenylation status of lncRNAs using end point and quantitative RT-PCR analysis of cDNA.

  • Methods to transduce human CD34+ cells with lentiviral vectors encoding for expression of a functional lncRNA and subsequently monitor Fas receptor levels by flow cytometry.

1. Data

Here we provide expression data for a focused set of lncRNAs during culture-induced differentiation of human CD34+ cells into erythroblasts (Table 1). We provide sequences for the cloned 5′ untranslated region (UTR) of Saf highlighting transcription factor binding sites including GATA-1, KLF1, and NF-κB, which were studied in detail in the research article (Fig. 1). We include relative transcript levels of GATA-1 and KLF1 in K562 human erythroleukemia cells and maturing human erythroblasts (Fig. 2, Fig. 3). We share end point and quantitative RT-PCR analysis of cDNA prepared from total RNA isolated from human erythroblasts using random hexamers versus oligo(dT)18 (Fig. 4). Finally, we include flow cytometry histograms demonstrating Fas surface levels on maturing erythroblasts derived from human CD34+ cells transduced using mock conditions or Saf-encoding lentivirus particles (Fig. 5).

Table 1.

Expression of lncRNAs during erythroid maturation.

lncRNA Fold change day 6 Fold change day 10
21A 0.71 1.45
AAA1 3.00 ND
aHIF 1.42 1.41
Ak023948* 0.50 0.33
ANRIL 5.66 ND
Anti-NOS2A** 2.83 10.49
BACE1AS 0.72 2.80
BC017743 5.68 ND
BC043430 2.76 ND
BC200 0.71 0.72
BCMS 0.71 1.42
Bic 1.39 0.71
CCND1 ANCR ND ND
CMPD 12.47 ND
DD3 5.67 ND
DGCR5 ND ND
DISC2 2.85 1.32
DLG2AS 11.40 ND
Ego 2.85 1.32
Gas5 0.71 2.82
Gomafu** 2.84 11.36
H19* 0.02 0.09
H19-AS ND ND
Har1a ND ND
Har1b ND 2.96
Hotair 12.14 ND
HotairM1* 0.36 0.36
HOTTIP 6.05 ND
Hoxa11as BE305073 ND ND
Hoxa1as AA489505 1.43 0.71
Hoxa3as BE873349 ND ND
Hoxa3as BI823151 3.05 ND
Hoxa6as AK092154 1.51 ND
HULC ND ND
I1pa16 11.37 ND
IGF2AS ND ND
IPW 1.41 0.71
KRASP1 1.43 2.79
lincRNA-SFMBT2 ND ND
lincRNA-VLDLR 11.32 ND
LIT 1.40 1.43
Loc285194 2.88 ND
LUST 0.72 2.81
Malat1** 2.43 5.65
MEG3 ND ND
MER11c 2.85 ND
NCRMS ND ND
NDM29 5.69 ND
NEAT1 0.71 5.63
PAR1 2.81 ND
PAR5 0.71 0.71
PCAT-1 11.33 ND
PCAT-14 6.07 ND
PCAT-29 ND ND
PCAT-32 11.45 ND
PCAT-43 1.47 ND
PCGEM1 1.52 ND
PR-AT2 1.43 2.81
PRINS ND ND
PSF inhibiting RNA 5.67 ND
PtenP1 0.71 1.41
RMRP 0.71 2.83
ROR 6.02 ND
Saf** 2.83 5.68
SCA8 2.86 ND
Sox2OT 11.38 ND
SRA 1.42 0.71
ST7OT1 1.42 2.82
ST7OT2 ND ND
ST7OT3 ND ND
ST7OT4 1.42 2.84
telomerase RNA 0.72 2.82
Tmevpg1 6.09 ND
TU_001762 9 3.03 ND
TUG1 0.71 1.42
UCA1 ND ND
WT-1as 11.38 ND
Y1** 2.42 5.58
Y3 1.41 2.83
Y4 1.41 1.41
Y5 1.42 0.71
Zeb2NAT 0.71 1.34

In bold are lncRNAs with a 2-fold *decrease or **increase on both days 6 and 10; ND, not detected.

Fig. 1.

Fig. 1.

Saf 5′ untranslated region and transcription factor binding sites. Saf promoter sequence (nucleotides −820 to –23 bp relative to Saf transcriptional start site) used in luciferase reporter assays. Underlined sequences are binding sites for GATA-1, KLF1, NF-κB, SP1, ETS, and c/EBPβ (CCAAT-enhancer binding protein).

Fig. 2.

Fig. 2.

Transcript levels of GATA-1 and KLF1 in maturing erythroid cells derived from CD34+ cells of independent ontology. Erythroid cells derived from fetal liver or adult bone marrow CD34+ cells exposed to identical conditions were collected during early, intermediate (mid), or late stages of differentiation. Cells were isolated of total RNA and levels of GATA-1 and KLF1 transcripts determined by quantitative RT-PCR. Data were normalized to RNAseP, set relative to fetal liver, and plotted as mean+SD; n=2 independent donors performed in duplicate.

Fig. 3.

Fig. 3.

GATA-1 and KLF1 expression in K562 cells and adult bone marrow-derived erythroid cells. Relative transcript levels of GATA-1 and KLF1 for K562 human erythroleukemia cells and adult bone marrow (BM CD34)-derived erythroblasts collected at late stage of culture. Data were normalized to RNAseP and mean levels plotted.

Fig. 4.

Fig. 4.

LncRNA Saf is not effectively polyadenylated. Total RNA was isolated from erythroblasts-derived from CD34+ cells on culture day 8 and reverse transcribed into cDNA using oligo(dT)18 or random hexamers. (A) End point RT-PCR of Saf lncRNA and RPL13A for cDNA produced with oligo(dT)18 (dT) or random hexamers (RH). M, 100-bp ladder. Vertical white lines have been inserted to represent repositioned lanes on gel images. (B) Real time quantitative RT-PCR analysis of Saf lncRNA for cDNA prepared using the indicate primers. Data were normalized to RPL13A and plotted as mean+SD; n=2 independent donors performed in triplicate.

Fig. 5.

Fig. 5.

LncRNA Saf overexpression in erythroblasts reduces surface expression of Fas. Human CD34+ cells from a single healthy donor were transduced using mock conditions or with lentiviral vector particles encoding for Saf. Flow cytometry histograms demonstrating surface levels of Fas receptor for mock (orange) and Saf (blue) transduced cells collected on days 6 and 10 post-transduction, times corresponding to proliferation and differentiation stages of culture. Dotted line depicts cells reacted with isotype control antibodies.

2. Experimental design, materials and methods

2.1. LncRNA quantitative RT-PCR array

CD34+ cells isolated from fetal liver (FL), umbilical cord blood (CB), or adult bone marrow (BM) were purchased commercially (Lonza; Walkersville, MD) and used in accordance with protocols approved by the Springfield Committee for Research Involving Human Subjects at Southern Illinois University School of Medicine. Samples for FL and BM were from two unrelated donors. CD34+ cells were cultured under conditions that promote erythroid differentiation as described [2]. Erythrocytes collected at early, intermediate and late stages of maturation were extracted of total RNA using spin columns (Ambion) with on-column DNase treatment (Promega). RNA was quantified by a Nanodrop 2000 (Life Technologies) and quality assessed by visualizing 18S and 28S ribosomal RNA bands separated through 1% agarose and stained with ethidium bromide. RNA (300 ng) was reverse transcribed into cDNA using SuperScript VILO Master Mix (Life Technologies) and conditions: 25 °C–10 min, 42 °C–60 min, 85 °C–5 min, 4 °C-hold. cDNA (40 ng/reaction) was used as template for a lncRNA PCR array (LncRNA Profiler™ qPCR Array, System Biosciences) that included primer sequences for 82 unique lncRNAs and 14 controls optimized for use with SYBR Green as the fluorophore. A version of this array has previously been validated [3]. Quantitative PCR reactions were performed with a StepOnePlus thermocycler (Applied Biosystems) using SYBR Green settings that included a melt curve. Changes in transcript levels were assessed by the delta-delta CT formula [4] with normalization to internal controls.

2.2. In silico analysis of Saf 5′ untranslated region (UTR)

We performed in silico analysis of genomic DNA within 1000-bp upstream of the Saf transcriptional start site. Transcription factor binding sites were identified using Geneious (v6.1.2, Biomatters Ltd.) and UCSC Genome Browser on Human Dec. 2013 (GRCh38/hg38) assembly (http://genome.ucsc.edu/) [5].

2.3. Relative expression of GATA-1 and KLF1

RNA, extracted from K562 human erythroleukemia cells or culture-differentiated human erythroblasts collected at early, intermediate and late stages of maturation, was reverse transcribed into cDNA as described in Section 2.1. Quantitative PCR was performed on a StepOnePlus thermocycler (Applied Biosystems) using cDNA (100 ng) and TaqMan primer:probe sets specific to GATA-1 (Hs01085823_m1; FAM), KLF1 (Hs00610592_m1; FAM), and RNaseP (4316844; VIC-TAMRA) all from Life Technologies. Changes in transcript levels were assessed by the delta-delta CT formula with normalization to RNAseP.

2.4. Saf polyadenylation status

RNA was extracted from CD34+-derived erythroblasts on day 8 in culture and subjected to first strand cDNA synthesis with either random hexamers or oligo(dT)18 according to the manufacturer׳s protocol (ThermoScientific). Resulting cDNAs (100 ng) were quantified with SYBR Green by real time PCR (StepOnePlus, Life Technologies) and analyzed by end point PCR using Saf primers (For: 5′-ATG TGA ACA TGG AAT CAT CAA GG-3′; Rev: 5′-GGA GAT TCA TGA GAA CCT TGG-3′) and RPL13A primers (For: 5′-CCT GGA GGA GAA GAG GAA AGA GA-3′; Rev: 5′ TTG AGG ACC TCT GTG TAT TTG TCA A-3′) as an internal control. End point PCR products were resolved on 2% agarose gels containing ethidium bromide and photographed.

2.5. Flow cytometry analysis of Fas on maturing erythroblasts

Flow cytometry studies were performed on a FACSAriaII (BD Biosciences) using FlowJo v10.0 analysis software. Human CD34+ cells transduced using mock conditions or with lentiviral vector particles encoding for Saf were collected on days 6 and 10 post-transduction, times corresponding to proliferation and differentiation stages of culture. Erythroblasts (1×105) were washed with PBS, suspended in staining medium (PBS+0.5% BSA) and reacted with allophycocyanin (APC)-conjugated mouse anti-human CD95 (DX2, BD Biosciences, 1:50 dilution); mouse anti-human IgG-APC was used as an isotype control.

2.6. Statistical analysis

Microsoft Excel or Prism 5 (GraphPad) were used to determine descriptive statistics (mean+SD).

Acknowledgments

We thank the flow cytometry laboratory of Melissa Roberts for expertize in flow cytometry. This work was supported by a Medical Innovators Grant from the Doris Duke Charitable Foundation (D.A.P. and A.W.). The Southern Illinois University School of Medicine flow cytometry equipment was supported by Award number S10RR025674 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Footnotes

Appendix A

Supplementary data associated with this article can be found in the online version at doi:10.1016/j.dib.2016.03.106.

Appendix A. Supplementary material

Supplementary material

mmc1.pdf (43.9KB, pdf)

References

  • 1.Villamizar O., Chambers C.B., Mo Y.-Y., Torry D.S., Hofstrand R., Riberdy J.M., Persons D.A., Wilber A. Fas-antisense long noncoding RNA is differentially expressed during maturation of human erythrocytes and confers resistance to Fas-mediated cell death. Blood Cells, Mol., Dis. 2016;58:57–66. doi: 10.1016/j.bcmd.2016.03.002. [DOI] [PubMed] [Google Scholar]
  • 2.Wilber A., Tschulena U., Hargrove P.W., Kim Y.-S., Persons D.A., Barbas C.F., Nienhuis A.W. A zinc-finger transcriptional activator designed to interact with the beta-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts. Blood. 2010;115:3033–3041. doi: 10.1182/blood-2009-08-240556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Liu Q., Huang J., Zhou N., Zhang Z., Zhang A., Lu Z., Wu F., Mo Y.-Y. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucl. Acids Res. 2013;41:4976–4987. doi: 10.1093/nar/gkt182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  • 5.UCSC Genome Browser, Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., Haussler D. The human genome browser at UCSC. Genome Res. 2002;12:996–1006. doi: 10.1101/gr.229102. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material

mmc1.pdf (43.9KB, pdf)

Articles from Data in Brief are provided here courtesy of Elsevier

RESOURCES